TCS’s optimistic outlook spurs market confidence

Despite missing Street estimates on the revenue and net profit front in its October-December earnings, analysts have viewed the company’s performance with a cautious optimism. The company’s commentary on the revival of discretionary spending and its robust order book are key drivers behind this sentiment.

However, analysts remain vigilant about the challenges of total contract value (TCV) conversion and sustained growth in emerging markets after the expected tapering of the BSNL deal.

Also ReadVolatile Friday for markets: Nifty, Sensex down over 2% this week; Nifty IT Index outperforms

The positive sentiment was reflected in the company’s stock performance on Friday. The company’s shares closed up 5.67% at Rs 4,265.55 on BSE, on a day the Sensex closed down 0.31% at 77,378.91.

TCS reported a consolidated net profit of Rs 12,380 crore, up 4% sequentially, but slightly below Bloomberg’s estimate of Rs 12,534 crore. Revenue for the quarter declined 0.4% sequentially to Rs 63,973 crore, missing the forecasted Rs 64,748 crore.

Despite the muted performance, analysts viewed the company’s $10.2 billion in new deal TCV – a significant jump from $8.6 billion in the previous quarter – as a promising sign. Motilal Oswal analysts noted, “While revenue numbers were flat, the deal win TCV signals potential momentum pick-up ahead. A recovery in discretionary client spending, coupled with a strong US economy, could set a more favourable growth stage for FY26”.

On Thursday, the TCS management highlighted early signs of a revival in discretionary spending across sectors, supported by customer conversations. Analysts from ICICI Securities pointed out, “Demand for discretionary projects is expected to strengthen amid lower interest rates, reduced inflation, and declining unemployment”.

Operating margins for the December quarter rose to 26.6%, up from 26% in Q2FY25, bolstered by effective cost management and favourable currency movements.

The $10.2 billion TCV recorded in the October-December quarter marked a sharp improvement, with analysts highlighting the absence of mega deals (above $500 million) in the mix. The growth instead stemmed from multiple mid-sized deals across diverse domains, including AI-driven fraud detection, cloud migration, S4 HANA transformations, and cybersecurity solutions.

“TCS is working on several mega deals. While deal tenures remain unchanged, decision cycles have shortened. This trend suggests better deal conversions in FY26,” ICICI Securities said in its report.

 » Read More

Related Articles

Stocks To Watch: From tech stocks to Vedanta, Mazagon Dock, HDFC Bank, 12 stocks in news today

The stock market is on edge after the US President Donald Trump announced new tariffs on Indian imports. Some sectors are set to gain, while others may feel the heat. Pharma stocks look steady, IT is facing pressure, and export-driven industries could see big swings. Apart from this, the latest corporate moves, major investments, and

LIVE: Can Nifty, Sensex beat global blues? Trump tariff trigger biggest 1-day fall since 2020 in US

Go to Live UpdatesSensex Nifty Today | Stock Market Live Updates: Markets are on the edge. The Reciprocal Tariff announced by US President Donald Trump triggered a massive selloff in the US Markets as it sparked recession fears. The US Indices- Dow Jones, S&P 500 and Nasdaq clocked their biggest single day losses in 5

2 Stocks trading below industry P/E – Buying opportunity?

Value investing, a term coined by Benjamin Graham, is a widely used concept in the global investment landscape. The concept often focuses on buying stocks and trading at low valuations, making such stocks attractive to investors looking for growth at a reasonable price, with a margin of safety. However, they require some catalysts, such as

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Stocks To Watch: From tech stocks to Vedanta, Mazagon Dock, HDFC Bank, 12 stocks in news today

The stock market is on edge after the US President Donald Trump announced new tariffs on Indian imports. Some sectors are set to gain, while others may feel the heat. Pharma stocks look steady, IT is facing pressure, and export-driven industries could see big swings. Apart from this, the latest corporate moves, major investments, and

LIVE: Can Nifty, Sensex beat global blues? Trump tariff trigger biggest 1-day fall since 2020 in US

Go to Live UpdatesSensex Nifty Today | Stock Market Live Updates: Markets are on the edge. The Reciprocal Tariff announced by US President Donald Trump triggered a massive selloff in the US Markets as it sparked recession fears. The US Indices- Dow Jones, S&P 500 and Nasdaq clocked their biggest single day losses in 5

2 Stocks trading below industry P/E – Buying opportunity?

Value investing, a term coined by Benjamin Graham, is a widely used concept in the global investment landscape. The concept often focuses on buying stocks and trading at low valuations, making such stocks attractive to investors looking for growth at a reasonable price, with a margin of safety. However, they require some catalysts, such as

GCCs, IT companies dominate office space

Quarterly transactions in the office market reached a historic high of 28.2 million square feet in the January-March period, shows a Knight Frank report.  Global capability centres (GCCs) were the largest consumers of office space during the period, accounting for 44% of the total transaction volume.  A resurgence in demand from the third-party IT services

Gems and jewellery units to take a big hit

The reciprocal tariff of 27% will jack up customs duties faced by Indian exporters of studded and gold jewellery in the US to 32-34%, including 5.5-7% extant tariffs. Diamond products which currently do not have any tariffs, will cost US importers a 27% import duty. Sabyasachi Ray, Executive Director of the Gems & Jewellery Export